The first stem cell spinal cord treatment study in the world is expected to begin this summer.
Wired PR News.com — Plans are set for the first stem cell treatment study in the world for spinal cord injury to begin. As reported by the Associated Press (AP), Geron Corp Biotech Company is expected to start the study this summer, after getting federal permission to test eight to ten paraplegic patients using injected cells obtained from embryonic cells.
As noted in the report, the patients’ injections will be administered within two weeks of their injury. Doctors and researchers will be primarily testing the treatment’s safety, however signs of its effectiveness will also be monitored. Ed Baetge of Novocell Inc., is quoted as regarding gaining approval for testing the procedure as “a milestone and it’s a breakthrough for the field.”
Rutgers University’s Dr. Wise Young is further quoted as stating, “a lot of hope of the spinal cord injury community is riding on this trial.”